Back to news

DaVita Falls as Post-Earnings Cost Pressure and Kidney-Care Policy Overhang Weigh on Shares

Investivoq PriceTracker

DaVita Inc. (DVA) is down 3.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to continued selling after DaVita’s third-quarter results, which showed solid revenue and adjusted earnings but also highlighted higher patient-care costs and a narrowed full-year outlook range. This could also be because investors are still digesting the new federal kidney-care policy push and the shareholder-lawyer investigations that followed the stock’s earlier post-earnings drop.

Details:

  • DaVita’s third-quarter release showed revenue of $3.578 billion and adjusted diluted earnings per share of $3.82.
  • The same release showed patient care costs per treatment rose to $280.22 from $277.40 in the prior quarter, suggesting margin pressure even as treatment trends remained fairly steady.
  • Management updated 2026 guidance to adjusted operating income of $2.175 billion to $2.25 billion and adjusted diluted EPS of $14.30 to $15.20, narrowing the top end of the earnings range versus the prior outlook.
  • Separate policy and legal headlines have added uncertainty: HHS unveiled a national kidney-care plan focused on more competition and patient choice, and investor-law-firm probes were announced shortly after the stock’s sharp decline in late October and early November.

    • Sources:

    DaVita Investor Relations, SEC, HHS, GlobeNewswire

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $DVA Insider Trading Activity

    DVA Insider Trades

    $DVA insiders have traded $DVA stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.

    Here’s a breakdown of recent trading of $DVA stock by insiders over the last 6 months:

    • HATHAWAY INC BERKSHIRE has made 0 purchases and 2 sales selling 565,543 shares for an estimated $105,539,326.
    • JAVIER RODRIGUEZ (Chief Executive Officer) has made 0 purchases and 2 sales selling 69,407 shares for an estimated $14,532,108.
    • DAVID PAUL MAUGHAN (Chief Operating Officer, DKC) has made 0 purchases and 2 sales selling 20,529 shares for an estimated $4,089,742.
    • KATHLEEN ALYCE WATERS (Chief Legal & Pub. Affairs Off) has made 0 purchases and 2 sales selling 15,405 shares for an estimated $3,210,376.
    • JAMES O HEARTY (Chief Compliance Officer) sold 15,000 shares for an estimated $2,909,745

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive DVA Data Alerts
    Get market-moving data, filings, and signals for DVA in real time.
    Sign Up

    $DVA Hedge Fund Activity

    We have seen 301 institutional investors add shares of $DVA stock to their portfolio, and 300 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • BERKSHIRE HATHAWAY INC removed 1,220,376 shares (-4.1%) from their portfolio in Q2 2026, for an estimated $271,509,252
    • BANK OF AMERICA CORP /DE/ added 410,940 shares (+170.5%) to their portfolio in Q2 2026, for an estimated $91,425,931
    • GEODE CAPITAL MANAGEMENT, LLC added 401,562 shares (+47.0%) to their portfolio in Q3 2026, for an estimated $70,241,225
    • NEUBERGER BERMAN GROUP LLC added 393,492 shares (+74.0%) to their portfolio in Q2 2026, for an estimated $87,544,100
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 365,569 shares (+inf%) to their portfolio in Q2 2026, for an estimated $81,331,791
    • WOODLINE PARTNERS LP removed 350,172 shares (-77.3%) from their portfolio in Q2 2026, for an estimated $77,906,266
    • UBS GROUP AG removed 345,349 shares (-53.1%) from their portfolio in Q2 2026, for an estimated $76,833,245

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $DVA Government Contracts

    We have seen $181,090,169 of award payments to $DVA over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    • EXPRESS REPORT: FY 26 NOVEMBER NDSC EXPRESS REPORT: $121,425,309
    • EXPRESS REPORT: FY 26 OCTOBER NDSC EXPRESS REPORT: $26,893,447
    • ON-SITE DIALYSIS SERVICES: $1,145,928

    To track government contracts to publicy traded companies, check out Investivoq's government contracts dashboard. You can access data on government contracts through the Investivoq API government contracts endpoint.

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.